Sarah E. Frew, PhD, MBA
Cell & Gene Therapy
& Business Development Advisor
Sarah has spent her career working to advance healthcare from all angles, including academic research, healthcare investing and in the biopharmaceutical industry. Currently she is Managing Partner of Go Far Advisors, which provides advisory services to life sciences companies, investors, and leading academic scientists to maximize the value of breakthrough advances.Previously, Sarah was Director of Corporate Contracts and Alliances at the Penn Center for Innovation at the University of Pennsylvania, where she identified commercial partnerships for the University’s research programs. As Director of Business and Commercial Development at TetraLogic Pharmaceuticals, Sarah played an integral role in the company’s M&A and financing transactions, including the company’s initial public offering on Nasdaq. Sarah has a PhD in cancer
biology from the Massachusetts Institute of Technology, an MBA from the Wharton School of the University of Pennsylvania and a BS in Biological Sciences from Carnegie Mellon University.